• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

DecImmune Therapeutics

edit

DecImmune Therapeutics, Inc., a biotechnology company, manufactures drugs for inflammation and autoimmunity. The company was incorporated in 2001 and is based in Boston, Massachusetts.

Recent Milestones

edit

• 
  DecImmune Therapeutics received $2.25M in Private Equity funding. (2/26/13)
  Posted 2/26/13 at 11:25pm via finsmes.com
• 
  DecImmune Therapeutics received $3.2M in Venture Round funding. (9/27/10)
  Posted 9/27/10 at 11:08pm via finsmes.com
• 
  DecImmune Therapeutics added Michael Carroll as Founders.
  Posted 2/26/13 at 11:29pm

Videos

Screenshots

edit

Sources

1. DecImmune Therapeutics Receives $1M in Equity Financing; $2.2M Phase II SBIR Funding (finsmes.com) [edit]
2. DecImmune Therapeutics Completes $2.25M Equity Financing (finsmes.com) [edit]